Genomics England
In a Nature Medicine paper, WGS yielded a clinical benefit for 24 percent of pediatric cancer patients, and directly changed clinical management for 7 percent.
UK Pilot Project to Develop Antisense Oligonucleotides for Children With Ultra-Rare Brain Disorders
The pilot, part of a new government-funded program, will test an end-to-end pathway covering diagnosis, individual therapy design and manufacturing, and treatment.
Metabolon, Genomics England Partner to Characterize Rare Disease Metabolomics
The collaboration aims to generate metabolomic data for over 7,000 participants from the UK's 100,000 Genomes Project.
Genomics England, AI Startup Collaborate on Immunotherapy
Cambridge Cancer Genomics will contribute AI, liquid biopsy technology, and a TMB sequencing panel to broaden access to cancer immunotherapies in the UK.